SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing significant attention as investors react to a cooling geopolitical environment in the Middle East and renewed institutional momentum, including high-profile ETF activity. The community is actively debating the sustainability of this price floor, with many focusing on whether recent support levels can serve as a catalyst for a sustained climb toward the three-thousand-dollar range.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as the community leans into its legacy as an early Bitcoin parody, with active discussions focusing on its long-standing cultural roots and potential for future growth. Supporters are actively engaging in the debate over its longevity, often contrasting its meme status with the more serious, established reputation of Bitcoin.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending as investors debate the impact of broader crypto market volatility and shifting institutional interest, with the community actively analyzing technical support levels amidst rumors of long-term utility-focused partnerships. Traders are heavily focused on the interplay between retail-centric adoption, potential regulatory clarity, and the broader rotation of capital as they monitor for signs of a market bottom.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors react to leadership transitions and renewed share buybacks, while the community intensely debates whether the company can maintain its compounding performance without Warren Buffett. Sentiment remains polarized, with many users frustrated by the stock's recent underperformance against broader indices while others view current price levels as a generational buying opportunity backed by a massive cash reserve.

Maulcoin

Maulcoin is gaining significant traction as a community-driven project, with members actively pushing its organic growth and anticipating upcoming catalysts like potential airdrops and chart updates. Investors are rallying around the "dark side" theme, viewing the current consolidation as a strategic accumulation phase before a potential move toward higher market capitalization.

Frontera Energy Corp. engages in the exploration, development, production, transportation, storage, and sale of oil and natural gas. It operates interests in exploration and production blocks in Colombia, Ecuador and Guyana, and pipeline and port facilities in Colombia. The company was founded on April 10, 1985 and is headquartered in Calgary, Canada.

Frontera Energy Corporation - Ordinary Shares New

Frontera Energy is generating intense market interest as the company shifts toward a strategic infrastructure-focused model, highlighted by the divestiture of its Colombian exploration assets to Parex Resources and the potential spin-off of its high-value Puerto Bahia port and pipeline assets. Investors are actively debating the total valuation of these remaining infrastructure holdings, with the community closely tracking whether the ongoing consolidation in the energy sector will trigger a broader acquisition of the company's remaining footprint, including its contested but high-potential Guyana exploration interests.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is seeing significant market momentum as investors react to the company's confirmed ability to meet U.S. domestic content requirements for 2026 tax credits, a major competitive advantage bolstered by its integrated software and hardware ecosystem. Community sentiment is increasingly bullish, with active discussions focusing on the massive project backlog, the strategic role of its storage solutions in supporting AI data center grid connectivity, and the potential for a short squeeze as institutional positioning continues to tighten.

Roundhill ETF Trust - Roundhill Memory ETF

Investors are increasingly focused on DRAM as a targeted vehicle for capturing the surging demand for high-bandwidth memory (HBM) essential to AI infrastructure and advanced computing. Community members are actively debating the ETF's potential as a specialized supply chain play versus the inherent risks associated with its narrow focus and the volatility common to newly launched thematic funds.

CD Projekt SA is a holding company, which engages in the development of video games. It operates through the CD PROJEKT RED and GOG.com segments. The CD PROJEKT RED segment focuses on videogame development. The GOG.com segment distributes global digital videogame. Its other activities include motion picture distribution and investment services. The company was founded by Marcin Piotr Iwinski in 1994 and is headquartered in Warsaw, Poland.

CD Projekt S.A. - ADR

CD Projekt 4 ADR Representing Ord Shs

CD Projekt is generating significant buzz as its highly anticipated Witcher 4 moves into full-scale production, bolstering investor confidence alongside strong sales momentum for the Cyberpunk 2077 franchise. The community remains deeply engaged with ongoing franchise expansions and the companys push into new platforms, viewing the long-term project pipeline as a key driver for future growth.

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

Upstream Bio Inc.

Upstream Bio is capturing investor attention as the community debates its clinical trial progress, with bulls highlighting the potential of verekitug to outperform existing blockbuster respiratory drugs and bears expressing frustration over recent price volatility. Traders are actively weighing the stock's discounted valuation against the risks of upcoming late-stage trial milestones and the competitive landscape for asthma and nasal polyp treatments.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

HC Wainwright Lifts Earnings Estimates for Aura Biosciences

Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) - Equities researchers at HC Wainwright increased their Q1 2026 earnings estimates for Aura Biosciences in a research report issued on Monday, March...

Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year?

Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

Aura Biosciences (NASDAQ:AURA) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised Aura Biosciences from a "sell" rating to a "hold" rating in a research report on Saturday...

Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's  What You Should Know

The mean of analysts' price targets for Aura Biosciences (AURA) points to a 201.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

FY2030 Earnings Forecast for AURA Issued By HC Wainwright

Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) - HC Wainwright issued their FY2030 earnings estimates for shares of Aura Biosciences in a report issued on Monday, March 30th. HC Wainwright analyst A. Maldonado forecasts that the company will earn ($0.35) per share for the year. HC Wainwright cur...

Aura Biosciences (NASDAQ:AURA) Earns Buy Rating from HC Wainwright

HC Wainwright restated a "buy" rating and set a $22.00 price objective on shares of Aura Biosciences in a research report on Monday...

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Rating of "Hold" by Brokerages

Shares of Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are covering the stock, Marketbeat Ratings reports. One...

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.

Aura Biosciences (AURA) to Release Earnings on Monday

Aura Biosciences (NASDAQ:AURA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

AURA
Aura Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AURA News

AURAAura Biosciences Inc